Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study

R Jiménez‐Bárcenas… - British Journal of …, 2024 - Wiley Online Library
Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an
increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase inhibitor, has been …
被引用次数：4 相关文章

Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study.

R Jiménez-Bárcenas… - British Journal of …, 2024 - europepmc.org
Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an
increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase inhibitor, has been …

Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study

R Jiménez-Bárcenas… - British journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an
increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase inhibitor, has been …